TY - JOUR AU - Harrington, K. J. AU - Billingham, L. J. AU - Brunner, T. B. AU - Burnet, N. G. AU - Chan, C. S. AU - Hoskin, P. PY - 2011 DA - 2011// TI - Guidelines for preclinical and early phase clinical assessment of novel radiosensitisers JO - Br J Cancer VL - 105 UR - https://doi.org/10.1038/bjc.2011.240 DO - 10.1038/bjc.2011.240 ID - Harrington2011 ER - TY - JOUR AU - Weichselbaum, R. R. AU - Liang, H. AU - Deng, L. AU - Fu, Y. -. X. PY - 2017 DA - 2017// TI - Radiotherapy and immunotherapy: a beneficial liaison? JO - Nat Rev Clin Oncol VL - 14 UR - https://doi.org/10.1038/nrclinonc.2016.211 DO - 10.1038/nrclinonc.2016.211 ID - Weichselbaum2017 ER - TY - JOUR AU - Deng, L. AU - Liang, H. AU - Xu, M. AU - Yang, X. AU - Burnette, B. AU - Arina, A. PY - 2014 DA - 2014// TI - STING-dependent cytosolic DNA sensing promotes radiation-induced type I interferon-dependent antitumor immunity in immunogenic tumors JO - Immunity VL - 41 UR - https://doi.org/10.1016/j.immuni.2014.10.019 DO - 10.1016/j.immuni.2014.10.019 ID - Deng2014 ER - TY - JOUR AU - Demaria, S. AU - Golden, E. B. AU - Formenti, S. C. PY - 2015 DA - 2015// TI - Role of local radiation therapy in cancer immunotherapy JO - JAMA Oncol VL - 1 UR - https://doi.org/10.1001/jamaoncol.2015.2756 DO - 10.1001/jamaoncol.2015.2756 ID - Demaria2015 ER - TY - JOUR AU - Formenti, S. C. AU - Demaria, S. PY - 2009 DA - 2009// TI - Systemic effects of local radiotherapy JO - Lancet Oncol VL - 10 UR - https://doi.org/10.1016/S1470-2045(09)70082-8 DO - 10.1016/S1470-2045(09)70082-8 ID - Formenti2009 ER - TY - JOUR AU - Golden, E. B. AU - Apetoh, L. PY - 2015 DA - 2015// TI - Radiotherapy and immunogenic cell death JO - Semin Radiat Oncol VL - 25 UR - https://doi.org/10.1016/j.semradonc.2014.07.005 DO - 10.1016/j.semradonc.2014.07.005 ID - Golden2015 ER - TY - JOUR AU - Topalian, S. L. AU - Taube, J. M. AU - Anders, R. A. AU - Pardoll, D. M. PY - 2016 DA - 2016// TI - Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy JO - Nat Rev Cancer VL - 16 UR - https://doi.org/10.1038/nrc.2016.36 DO - 10.1038/nrc.2016.36 ID - Topalian2016 ER - TY - JOUR AU - Boussiotis, V. A. PY - 2016 DA - 2016// TI - Molecular and biochemical aspects of the PD-1 checkpoint pathway. Longo DL JO - N Engl J Med VL - 375 UR - https://doi.org/10.1056/NEJMra1514296 DO - 10.1056/NEJMra1514296 ID - Boussiotis2016 ER - TY - JOUR AU - Pardoll, D. M. PY - 2012 DA - 2012// TI - The blockade of immune checkpoints in cancer immunotherapy JO - Nat Rev Cancer VL - 12 UR - https://doi.org/10.1038/nrc3239 DO - 10.1038/nrc3239 ID - Pardoll2012 ER - TY - STD TI - Gong J, Chehrazi-Raffle A, Reddi S, Salgia R. Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations. J Immunother Cancer. 2018 [cited 2018 Feb 8];6. Available from: https://jitc.biomedcentral.com/articles/10.1186/s40425-018-0316-z UR - https://jitc.biomedcentral.com/articles/10.1186/s40425-018-0316-z ID - ref10 ER - TY - JOUR AU - Deng, L. AU - Liang, H. AU - Burnette, B. AU - Beckett, M. AU - Darga, T. AU - Weichselbaum, R. R. PY - 2014 DA - 2014// TI - Irradiation and anti–PD-L1 treatment synergistically promote antitumor immunity in mice JO - J Clin Invest VL - 124 UR - https://doi.org/10.1172/JCI67313 DO - 10.1172/JCI67313 ID - Deng2014 ER - TY - JOUR AU - Dovedi, S. J. AU - Adlard, A. L. AU - Lipowska-Bhalla, G. AU - McKenna, C. AU - Jones, S. AU - Cheadle, E. J. PY - 2014 DA - 2014// TI - Acquired resistance to fractionated radiotherapy can be overcome by concurrent PD-L1 blockade JO - Cancer Res VL - 74 UR - https://doi.org/10.1158/0008-5472.CAN-14-1258 DO - 10.1158/0008-5472.CAN-14-1258 ID - Dovedi2014 ER - TY - STD TI - Dovedi SJ, Cheadle EJ, Popple A, Poon E, Morrow M, Stewart R, et al. Fractionated radiation therapy stimulates anti-tumor immunity mediated by both resident and infiltrating polyclonal T-cell populations when combined with PD1 blockade. Clin Cancer Res. 2017;clincanres.1673.2016. ID - ref13 ER - TY - STD TI - Vatner RE, Cooper BT, Vanpouille-Box C, Demaria S, Formenti SC. Combinations of Immunotherapy and Radiation in Cancer Therapy. Front Oncol. 2014 [cited 2017 Mar 4];28;4:325. Available from: http://journal.frontiersin.org/article/10.3389/fonc.2014.00325/abstract UR - http://journal.frontiersin.org/article/10.3389/fonc.2014.00325/abstract ID - ref14 ER - TY - JOUR AU - Sharma, R. A. AU - Plummer, R. AU - Stock, J. K. AU - Greenhalgh, T. A. AU - Ataman, O. AU - Kelly, S. PY - 2016 DA - 2016// TI - Clinical development of new drug–radiotherapy combinations JO - Nat Rev Clin Oncol VL - 13 UR - https://doi.org/10.1038/nrclinonc.2016.79 DO - 10.1038/nrclinonc.2016.79 ID - Sharma2016 ER - TY - JOUR AU - Chen, D. S. AU - Mellman, I. PY - 2013 DA - 2013// TI - Oncology meets immunology: the cancer-immunity cycle JO - Immunity VL - 39 UR - https://doi.org/10.1016/j.immuni.2013.07.012 DO - 10.1016/j.immuni.2013.07.012 ID - Chen2013 ER - TY - JOUR AU - Gupta, A. AU - Probst, H. C. AU - Vuong, V. AU - Landshammer, A. AU - Muth, S. AU - Yagita, H. PY - 2012 DA - 2012// TI - Radiotherapy promotes tumor-specific effector CD8+ T cells via dendritic cell activation JO - J Immunol VL - 189 UR - https://doi.org/10.4049/jimmunol.1200563 DO - 10.4049/jimmunol.1200563 ID - Gupta2012 ER - TY - JOUR AU - Norton, L. AU - Simon, R. AU - Brereton, H. D. AU - Bogden, A. E. PY - 1976 DA - 1976// TI - Predicting the course of Gompertzian growth JO - Nature VL - 264 UR - https://doi.org/10.1038/264542a0 DO - 10.1038/264542a0 ID - Norton1976 ER - TY - JOUR AU - Altrock, P. M. AU - Liu, L. L. AU - Michor, F. PY - 2015 DA - 2015// TI - The mathematics of cancer: integrating quantitative models JO - Nat Rev Cancer VL - 15 UR - https://doi.org/10.1038/nrc4029 DO - 10.1038/nrc4029 ID - Altrock2015 ER - TY - JOUR AU - Barbolosi, D. AU - Ciccolini, J. AU - Lacarelle, B. AU - Barlési, F. AU - André, N. PY - 2016 DA - 2016// TI - Computational oncology--mathematical modelling of drug regimens for precision medicine JO - Nat Rev Clin Oncol VL - 13 UR - https://doi.org/10.1038/nrclinonc.2015.204 DO - 10.1038/nrclinonc.2015.204 ID - Barbolosi2016 ER - TY - JOUR AU - Brenner, D. J. AU - Hlatky, L. R. AU - Hahnfeldt, P. J. AU - Huang, Y. AU - Sachs, R. K. PY - 1998 DA - 1998// TI - The linear-quadratic model and most other common radiobiological models result in similar predictions of time-dose relationships JO - Radiat Res VL - 150 UR - https://doi.org/10.2307/3579648 DO - 10.2307/3579648 ID - Brenner1998 ER - TY - JOUR AU - Leder, K. AU - Pitter, K. AU - LaPlant, Q. AU - Hambardzumyan, D. AU - Ross, B. D. AU - Chan, T. A. PY - 2014 DA - 2014// TI - Mathematical modeling of PDGF-driven glioblastoma reveals optimized radiation dosing schedules JO - Cell VL - 156 UR - https://doi.org/10.1016/j.cell.2013.12.029 DO - 10.1016/j.cell.2013.12.029 ID - Leder2014 ER - TY - JOUR AU - Poleszczuk, J. T. AU - Luddy, K. A. AU - Prokopiou, S. AU - Robertson-Tessi, M. AU - Moros, E. G. AU - Fishman, M. PY - 2016 DA - 2016// TI - Abscopal benefits of localized radiotherapy depend on activated T-cell trafficking and distribution between metastatic lesions JO - Cancer Res VL - 76 UR - https://doi.org/10.1158/0008-5472.CAN-15-1423 DO - 10.1158/0008-5472.CAN-15-1423 ID - Poleszczuk2016 ER - TY - JOUR AU - Serre, R. AU - Benzekry, S. AU - Padovani, L. AU - Meille, C. AU - Andre, N. AU - Ciccolini, J. PY - 2016 DA - 2016// TI - Mathematical modeling of cancer immunotherapy and its synergy with radiotherapy JO - Cancer Res VL - 76 UR - https://doi.org/10.1158/0008-5472.CAN-15-3567 DO - 10.1158/0008-5472.CAN-15-3567 ID - Serre2016 ER - TY - JOUR AU - Liang, H. AU - Deng, L. AU - Chmura, S. AU - Burnette, B. AU - Liadis, N. AU - Darga, T. PY - 2013 DA - 2013// TI - Radiation-induced equilibrium is a balance between tumor cell proliferation and T cell-mediated killing JO - J Immunol VL - 190 UR - https://doi.org/10.4049/jimmunol.1202612 DO - 10.4049/jimmunol.1202612 ID - Liang2013 ER - TY - JOUR AU - Parra-Guillen, Z. P. AU - Berraondo, P. AU - Grenier, E. AU - Ribba, B. AU - Troconiz, I. F. PY - 2013 DA - 2013// TI - Mathematical model approach to describe tumour response in mice after vaccine administration and its applicability to immune-stimulatory cytokine-based strategies JO - AAPS J VL - 15 UR - https://doi.org/10.1208/s12248-013-9483-5 DO - 10.1208/s12248-013-9483-5 ID - Parra-Guillen2013 ER - TY - JOUR AU - Lesterhuis, W. J. AU - Bosco, A. AU - Millward, M. J. AU - Small, M. AU - Nowak, A. K. AU - Lake, R. A. PY - 2017 DA - 2017// TI - Dynamic versus static biomarkers in cancer immune checkpoint blockade: unravelling complexity JO - Nat Rev Drug Discov VL - 16 UR - https://doi.org/10.1038/nrd.2016.233 DO - 10.1038/nrd.2016.233 ID - Lesterhuis2017 ER - TY - JOUR AU - Mosely, S. I. S. AU - Prime, J. E. AU - Sainson, R. C. A. AU - Koopmann, J. -. O. AU - Wang, D. Y. Q. AU - Greenawalt, D. M. PY - 2017 DA - 2017// TI - Rational selection of syngeneic preclinical tumor models for immunotherapeutic drug discovery JO - Cancer Immunol Res. VL - 5 UR - https://doi.org/10.1158/2326-6066.CIR-16-0114 DO - 10.1158/2326-6066.CIR-16-0114 ID - Mosely2017 ER - TY - JOUR AU - Klug, F. AU - Prakash, H. AU - Huber, P. E. AU - Seibel, T. AU - Bender, N. AU - Halama, N. PY - 2013 DA - 2013// TI - Low-dose irradiation programs macrophage differentiation to an iNOS+/M1 phenotype that orchestrates effective T cell immunotherapy JO - Cancer Cell VL - 24 UR - https://doi.org/10.1016/j.ccr.2013.09.014 DO - 10.1016/j.ccr.2013.09.014 ID - Klug2013 ER - TY - JOUR AU - Seifert, L. AU - Werba, G. AU - Tiwari, S. AU - Giao Ly, N. N. AU - Nguy, S. AU - Alothman, S. PY - 2016 DA - 2016// TI - Radiation therapy induces macrophages to suppress T-cell responses against pancreatic tumors in mice JO - Gastroenterology VL - 150 UR - https://doi.org/10.1053/j.gastro.2016.02.070 DO - 10.1053/j.gastro.2016.02.070 ID - Seifert2016 ER - TY - JOUR AU - Shiao, S. L. AU - Ruffell, B. AU - DeNardo, D. G. AU - Faddegon, B. A. AU - Park, C. C. AU - Coussens, L. M. PY - 2015 DA - 2015// TI - TH2-polarized CD4+ T cells and macrophages limit efficacy of radiotherapy JO - Cancer Immunol Res VL - 3 UR - https://doi.org/10.1158/2326-6066.CIR-14-0232 DO - 10.1158/2326-6066.CIR-14-0232 ID - Shiao2015 ER - TY - JOUR AU - Filatenkov, A. AU - Baker, J. AU - Mueller, A. M. S. AU - Kenkel, J. AU - Ahn, G. -. O. AU - Dutt, S. PY - 2015 DA - 2015// TI - Ablative tumor radiation can change the tumor immune cell microenvironment to induce durable complete remissions JO - Clin Cancer Res VL - 21 UR - https://doi.org/10.1158/1078-0432.CCR-14-2824 DO - 10.1158/1078-0432.CCR-14-2824 ID - Filatenkov2015 ER - TY - JOUR AU - Brenner, D. J. PY - 2008 DA - 2008// TI - The linear-quadratic model is an appropriate methodology for determining Isoeffective doses at large doses per fraction JO - Semin Radiat Oncol VL - 18 UR - https://doi.org/10.1016/j.semradonc.2008.04.004 DO - 10.1016/j.semradonc.2008.04.004 ID - Brenner2008 ER - TY - JOUR AU - Kirkpatrick, J. P. AU - Meyer, J. J. AU - Marks, L. B. PY - 2008 DA - 2008// TI - The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery JO - Semin Radiat Oncol VL - 18 UR - https://doi.org/10.1016/j.semradonc.2008.04.005 DO - 10.1016/j.semradonc.2008.04.005 ID - Kirkpatrick2008 ER - TY - JOUR AU - Barker, H. E. AU - Paget, J. T. E. AU - Khan, A. A. AU - Harrington, K. J. PY - 2015 DA - 2015// TI - The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence JO - Nat Rev Cancer VL - 15 UR - https://doi.org/10.1038/nrc3958 DO - 10.1038/nrc3958 ID - Barker2015 ER - TY - STD TI - Kang J, Demaria S, Formenti S. Current clinical trials testing the combination of immunotherapy with radiotherapy. J Immunother Cancer. 2016 [cited 2017 May 30];4:51. Available from: http://jitc.biomedcentral.com/articles/10.1186/s40425-016-0156-7 UR - http://jitc.biomedcentral.com/articles/10.1186/s40425-016-0156-7 ID - ref36 ER - TY - JOUR AU - Rangarajan, A. AU - Weinberg, R. A. PY - 2003 DA - 2003// TI - Opinion: comparative biology of mouse versus human cells: modelling human cancer in mice JO - Nat Rev Cancer VL - 3 UR - https://doi.org/10.1038/nrc1235 DO - 10.1038/nrc1235 ID - Rangarajan2003 ER - TY - JOUR AU - Pike, L. R. G. AU - Bang, A. AU - Ott, P. AU - Balboni, T. AU - Taylor, A. AU - Catalano, P. PY - 2017 DA - 2017// TI - Radiation and PD-1 inhibition: favorable outcomes after brain-directed radiation JO - Radiother Oncol VL - 124 UR - https://doi.org/10.1016/j.radonc.2017.06.006 DO - 10.1016/j.radonc.2017.06.006 ID - Pike2017 ER - TY - JOUR AU - Ahmed, K. A. AU - Stallworth, D. G. AU - Kim, Y. AU - Johnstone, P. A. S. AU - Harrison, L. B. AU - Caudell, J. J. PY - 2016 DA - 2016// TI - Clinical outcomes of melanoma brain metastases treated with stereotactic radiation and anti-PD-1 therapy JO - Ann Oncol VL - 27 UR - https://doi.org/10.1093/annonc/mdv622 DO - 10.1093/annonc/mdv622 ID - Ahmed2016 ER - TY - JOUR AU - Qian, J. M. AU - Yu, J. B. AU - Kluger, H. M. AU - Chiang, V. L. S. PY - 2016 DA - 2016// TI - Timing and type of immune checkpoint therapy affect the early radiographic response of melanoma brain metastases to stereotactic radiosurgery: immunotherapy and SRS in brain metastases JO - Cancer VL - 122 UR - https://doi.org/10.1002/cncr.30138 DO - 10.1002/cncr.30138 ID - Qian2016 ER - TY - JOUR AU - Kokolus, K. M. AU - Capitano, M. L. AU - Lee, C. -. T. AU - Eng, J. W. -. L. AU - Waight, J. D. AU - Hylander, B. L. PY - 2013 DA - 2013// TI - Baseline tumor growth and immune control in laboratory mice are significantly influenced by subthermoneutral housing temperature JO - Proc Natl Acad Sci VL - 110 UR - https://doi.org/10.1073/pnas.1304291110 DO - 10.1073/pnas.1304291110 ID - Kokolus2013 ER - TY - JOUR AU - Kim, P. S. AU - Lee, P. P. AU - Levy, D. PY - 2007 DA - 2007// TI - Modeling regulation mechanisms in the immune system JO - J Theor Biol VL - 246 UR - https://doi.org/10.1016/j.jtbi.2006.12.012 DO - 10.1016/j.jtbi.2006.12.012 ID - Kim2007 ER - TY - JOUR AU - Thompson, E. D. AU - Enriquez, H. L. AU - Fu, Y. -. X. AU - Engelhard, V. H. PY - 2010 DA - 2010// TI - Tumor masses support naive T cell infiltration, activation, and differentiation into effectors JO - J Exp Med VL - 207 UR - https://doi.org/10.1084/jem.20092454 DO - 10.1084/jem.20092454 ID - Thompson2010 ER - TY - JOUR AU - Gowrishankar, K. AU - Gunatilake, D. AU - Gallagher, S. J. AU - Tiffen, J. AU - Rizos, H. AU - Hersey, P. PY - 2015 DA - 2015// TI - Inducible but not constitutive expression of PD-L1 in human melanoma cells is dependent on activation of NF-κB. Cheriyath V JO - PLoS One VL - 10 UR - https://doi.org/10.1371/journal.pone.0123410 DO - 10.1371/journal.pone.0123410 ID - Gowrishankar2015 ER - TY - JOUR AU - Asaithamby, A. AU - Chen, D. J. PY - 2009 DA - 2009// TI - Cellular responses to DNA double-strand breaks after low-dose -irradiation JO - Nucleic Acids Res VL - 37 UR - https://doi.org/10.1093/nar/gkp237 DO - 10.1093/nar/gkp237 ID - Asaithamby2009 ER - TY - JOUR AU - Williams, M. V. AU - Denekamp, J. AU - Fowler, J. F. PY - 1985 DA - 1985// TI - A review of alpha/beta ratios for experimental tumors: implications for clinical studies of altered fractionation JO - Int J Radiat Oncol Biol Phys VL - 11 UR - https://doi.org/10.1016/0360-3016(85)90366-9 DO - 10.1016/0360-3016(85)90366-9 ID - Williams1985 ER - TY - STD TI - Watanabe Y, Dahlman EL, Leder KZ, Hui SK. A mathematical model of tumor growth and its response to single irradiation. Theor Biol Med Model. 2016 [cited 2017 Mar 4];27;13:6. Available from: http://www.tbiomed.com/content/13/1/6 UR - http://www.tbiomed.com/content/13/1/6 ID - ref47 ER - TY - JOUR AU - Selby, M. J. AU - Engelhardt, J. J. AU - Quigley, M. AU - Henning, K. A. AU - Chen, T. AU - Srinivasan, M. PY - 2013 DA - 2013// TI - Anti-CTLA-4 antibodies of IgG2a isotype enhance antitumor activity through reduction of Intratumoral regulatory T cells JO - Cancer Immunol Res. VL - 1 UR - https://doi.org/10.1158/2326-6066.CIR-13-0013 DO - 10.1158/2326-6066.CIR-13-0013 ID - Selby2013 ER -